Enteric Disease Testing Market Revenue to Attain USD 8.09 Bn by 2035

Published: 01 Apr 2026

Author: Precedence Research

Share:

Enteric Disease Testing Market Revenue and Trends 2026 to 2035

The global enteric disease testing market revenue surpassed USD 4.30 billion in 2025 and is predicted to attain around USD 8.09 billion by 2035, growing at a CAGR of 6.52%. The surging demand for preventive healthcare solutions, coupled with technological advancements in the diagnostics infrastructure, has driven the market expansion.

What Factors are Accelerating the Growth of the Enteric Disease Testing Market?

Several factors are driving the growth of the enteric disease testing market. Firstly, the increasing cases of typhoid fever and shigellosis. Secondly, numerous government initiatives are aimed at developing the public hospital infrastructure. Thirdly, the surging investment by private companies in opening new diagnostic facilities is driving the market growth.

Segment Insights

• By disease type, the bacterial enteric disease segment held the largest market share of 55.1% in 2025 due to the high prevalence of bacterial infections such as Salmonella and Escherichia coli, which are major causes of gastroenteritis worldwide. This significantly boosts the adoption of stool antigen assays and multiplex PCR for testing gastrointestinal disorders. Additionally, the surging prevalence of shigellosis in various Asian countries, such as India, Vietnam, and Bangladesh, has increased the demand for enteric disease testing.
• By technology, the molecular held a major market share of 45.0% in 2025, owing to the high efficacy of multiplex PCR panels to identify multiple pathogens in one stool sample. Additionally, numerous benefits of molecular testing, including high sensitivity, superior accuracy, and enhanced speed in detecting diseases, have boosted its adoption.
• By product & service, the reagents & consumables segment dominated the market in 2025 due to the increasing application of reagents to isolate, identify, and quantify specific microorganisms. Additionally, the surging demand for culture plates, extraction kits, pipette tips, and vials from the laboratories has fostered the segmental expansion.
• By end-user, the hospital laboratories segment held the highest share in 2025, driven by significant investments by hospitals in integrating advanced equipment in laboratories for delivering accurate results. In addition, the rising adoption of molecular testing technology by hospital labs for testing enteric diseases is accelerating the segmental growth.

Regional Insights

North America held the largest share of the global enteric disease testing market in 2025 due to its well-established healthcare infrastructure and the growing emphasis among patients on regular checkups to maintain good health. In addition, the increasing adoption of molecular testing by healthcare professionals for diagnosing amebiasis, as well as the opening of diagnostic centers in rural areas, has contributed to the market expansion.

Asia Pacific is expected to expand at the highest CAGR in the market during the forecast period, owing to the rapid investment by the government in providing high-quality treatment, coupled with the rising popularity of Point-of-care testing (POCT) in the hospitals of China and India. Moreover, the increasing cases of viral diseases and collaborations among private and public entities to establish modern healthcare facilities are likely to drive the market.

Enteric Disease Testing Market Coverage

Recent Development

• In October 2025, Hologic, Inc. announced that the U.S. Food and Drug Administration (FDA) approved Panther Fusion gastrointestinal (GI) bacterial and expanded bacterial assays. This test is performed to detect bacterial pathogens that cause infectious gastroenteritis.(Source: https://www.hologic.com)

Get this report to explore global market size, share, CAGR, and trends, featuring detailed segmental analysis and an insightful competitive landscape overview @ https://www.precedenceresearch.com/sample/8259

You can place an order or ask any questions, please feel free to contact us at sales@precedenceresearch.com |+1 804 441 9344